Guangdong VTR Bio-Tech Co., Ltd. (SHE:300381)
7.42
+0.17 (2.34%)
May 12, 2026, 3:04 PM CST
Guangdong VTR Bio-Tech Revenue
Guangdong VTR Bio-Tech had revenue of 212.65M CNY in the quarter ending March 31, 2026, with 5.06% growth. This brings the company's revenue in the last twelve months to 842.50M, up 1.54% year-over-year. In the year 2025, Guangdong VTR Bio-Tech had annual revenue of 832.26M with 0.73% growth.
Revenue (ttm)
842.50M
Revenue Growth
+1.54%
P/S Ratio
4.23
Revenue / Employee
764.52K
Employees
1,102
Market Cap
3.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 832.26M | 6.05M | 0.73% |
| Dec 31, 2024 | 826.20M | 30.18M | 3.79% |
| Dec 31, 2023 | 796.02M | -377.98M | -32.20% |
| Jan 1, 2023 | 1.17B | -718.15M | -37.95% |
| Jan 1, 2022 | 1.89B | -22.60M | -1.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beijing Kawin Technology Share-Holding | 1.30B |
| Hubei Goto Biopharm | 628.90M |
| Zhejiang Shouxiangu Pharmaceutical | 625.30M |
| Landfar Bio-medicine | 512.79M |
| Shanghai Model Organisms Center | 432.55M |
| Guanhao Biotech | 386.40M |
| Jiangsu Sihuan Bioengineering | 381.71M |
| Yantai Zhenghai Biotechnology | 347.75M |